PDCD1 and neoplasm: Given the inhibitory effect of JDB153 on LL2 cell growth and proliferation, we established a subcutaneous tumor model using LL2 cell to assess the therapeutic effect of JDB153 alone or in combination with anti‐PD1 antibody (PD‐1 Ab).